 Sarah Tevis
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 34 | 2025 | 2133 | 9.030 |
Why?
| | Patient Reported Outcome Measures | 9 | 2025 | 374 | 3.710 |
Why?
| | Mastectomy | 15 | 2025 | 132 | 3.590 |
Why?
| | Mastectomy, Segmental | 9 | 2025 | 86 | 3.020 |
Why?
| | Postoperative Complications | 20 | 2023 | 2477 | 2.520 |
Why?
| | Mammography | 5 | 2024 | 146 | 2.120 |
Why?
| | Surgical Procedures, Operative | 9 | 2024 | 244 | 2.060 |
Why?
| | Internship and Residency | 7 | 2022 | 1050 | 2.050 |
Why?
| | Mammaplasty | 3 | 2022 | 101 | 1.910 |
Why?
| | Drug Prescriptions | 4 | 2025 | 248 | 1.850 |
Why?
| | General Surgery | 5 | 2021 | 153 | 1.790 |
Why?
| | Patient Satisfaction | 6 | 2024 | 633 | 1.760 |
Why?
| | Pain, Postoperative | 6 | 2025 | 235 | 1.740 |
Why?
| | Health Literacy | 3 | 2024 | 160 | 1.630 |
Why?
| | Patient Readmission | 12 | 2019 | 653 | 1.630 |
Why?
| | Analgesics, Opioid | 6 | 2025 | 913 | 1.590 |
Why?
| | Quality of Life | 11 | 2025 | 2688 | 1.420 |
Why?
| | Breast Implants | 2 | 2022 | 20 | 1.380 |
Why?
| | Prophylactic Mastectomy | 2 | 2021 | 8 | 1.380 |
Why?
| | Humans | 88 | 2025 | 129625 | 1.230 |
Why?
| | Female | 61 | 2025 | 68734 | 1.180 |
Why?
| | Colectomy | 4 | 2016 | 93 | 1.180 |
Why?
| | Communication | 3 | 2023 | 838 | 1.150 |
Why?
| | Surveys and Questionnaires | 17 | 2025 | 5415 | 1.140 |
Why?
| | Patient Safety | 4 | 2021 | 287 | 1.130 |
Why?
| | Ovarian Neoplasms | 2 | 2023 | 484 | 1.130 |
Why?
| | Electronic Health Records | 3 | 2024 | 973 | 1.100 |
Why?
| | Comprehension | 3 | 2024 | 164 | 1.080 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 442 | 1.070 |
Why?
| | Ovariectomy | 3 | 2023 | 135 | 1.010 |
Why?
| | Quality Improvement | 10 | 2021 | 1101 | 1.000 |
Why?
| | Breast | 3 | 2023 | 153 | 0.980 |
Why?
| | Surgeons | 4 | 2023 | 264 | 0.960 |
Why?
| | Aged | 29 | 2025 | 22061 | 0.960 |
Why?
| | Patients | 2 | 2023 | 169 | 0.950 |
Why?
| | Adult | 32 | 2025 | 35599 | 0.940 |
Why?
| | Nomograms | 2 | 2015 | 47 | 0.940 |
Why?
| | Meaningful Use | 1 | 2024 | 13 | 0.920 |
Why?
| | Preoperative Care | 2 | 2024 | 338 | 0.840 |
Why?
| | Physicians | 2 | 2023 | 866 | 0.840 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 2 | 2022 | 19 | 0.830 |
Why?
| | Middle Aged | 29 | 2025 | 31136 | 0.820 |
Why?
| | Medical Errors | 2 | 2021 | 104 | 0.810 |
Why?
| | Hysterectomy | 2 | 2023 | 118 | 0.800 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1271 | 0.800 |
Why?
| | Patient Education as Topic | 2 | 2024 | 737 | 0.790 |
Why?
| | Literacy | 1 | 2022 | 10 | 0.780 |
Why?
| | Quality of Health Care | 3 | 2018 | 604 | 0.780 |
Why?
| | Delayed Diagnosis | 2 | 2020 | 79 | 0.750 |
Why?
| | Referral and Consultation | 3 | 2024 | 730 | 0.750 |
Why?
| | Colonic Neoplasms | 1 | 2024 | 242 | 0.750 |
Why?
| | Paternalism | 1 | 2021 | 4 | 0.730 |
Why?
| | Chemoprevention | 1 | 2021 | 91 | 0.700 |
Why?
| | Surgical Wound Infection | 2 | 2022 | 283 | 0.700 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.700 |
Why?
| | Oxycodone | 1 | 2021 | 43 | 0.700 |
Why?
| | Retrospective Studies | 22 | 2025 | 14522 | 0.690 |
Why?
| | Personnel Selection | 1 | 2021 | 70 | 0.680 |
Why?
| | Specialties, Surgical | 1 | 2021 | 74 | 0.680 |
Why?
| | Patient-Centered Care | 3 | 2022 | 508 | 0.670 |
Why?
| | Carcinoma, Lobular | 1 | 2020 | 47 | 0.670 |
Why?
| | Faculty | 1 | 2021 | 137 | 0.660 |
Why?
| | Risk Management | 1 | 2020 | 90 | 0.660 |
Why?
| | Breast Implantation | 1 | 2019 | 13 | 0.640 |
Why?
| | Radiology | 1 | 2021 | 159 | 0.640 |
Why?
| | Ileus | 2 | 2015 | 12 | 0.610 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 178 | 0.610 |
Why?
| | Prognosis | 9 | 2024 | 3774 | 0.600 |
Why?
| | Length of Stay | 9 | 2019 | 1122 | 0.600 |
Why?
| | Sentinel Lymph Node | 1 | 2018 | 42 | 0.600 |
Why?
| | Financing, Personal | 1 | 2018 | 26 | 0.590 |
Why?
| | Intraoperative Care | 1 | 2018 | 46 | 0.590 |
Why?
| | Interviews as Topic | 1 | 2021 | 704 | 0.590 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2018 | 80 | 0.590 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2024 | 958 | 0.580 |
Why?
| | HLA Antigens | 1 | 2019 | 234 | 0.580 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 761 | 0.570 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 276 | 0.570 |
Why?
| | Neoplasm, Residual | 1 | 2018 | 121 | 0.560 |
Why?
| | Pain Management | 1 | 2020 | 324 | 0.540 |
Why?
| | Students, Medical | 1 | 2021 | 322 | 0.530 |
Why?
| | Lymph Node Excision | 3 | 2023 | 164 | 0.520 |
Why?
| | Research Design | 1 | 2022 | 1045 | 0.520 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 880 | 0.520 |
Why?
| | Anastomotic Leak | 1 | 2016 | 39 | 0.510 |
Why?
| | Follow-Up Studies | 8 | 2025 | 4894 | 0.500 |
Why?
| | Genetic Testing | 1 | 2018 | 430 | 0.500 |
Why?
| | Prospective Studies | 8 | 2022 | 7135 | 0.490 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2015 | 6 | 0.480 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 483 | 0.470 |
Why?
| | Neoplasms | 3 | 2024 | 2455 | 0.440 |
Why?
| | Sentinel Lymph Node Biopsy | 5 | 2023 | 108 | 0.440 |
Why?
| | Hospitals, Teaching | 1 | 2014 | 114 | 0.440 |
Why?
| | Burnout, Professional | 1 | 2020 | 405 | 0.440 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 740 | 0.430 |
Why?
| | Health Care Surveys | 2 | 2015 | 557 | 0.430 |
Why?
| | Salpingo-oophorectomy | 2 | 2023 | 18 | 0.420 |
Why?
| | United States | 12 | 2024 | 13871 | 0.410 |
Why?
| | Carcinoma | 1 | 2015 | 214 | 0.410 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1164 | 0.410 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2720 | 0.410 |
Why?
| | Rectal Neoplasms | 1 | 2013 | 134 | 0.400 |
Why?
| | Surgical Oncology | 2 | 2022 | 22 | 0.390 |
Why?
| | Risk Factors | 16 | 2025 | 9786 | 0.390 |
Why?
| | Stress, Psychological | 1 | 2020 | 1068 | 0.390 |
Why?
| | Time-to-Treatment | 1 | 2013 | 179 | 0.380 |
Why?
| | Clinical Competence | 2 | 2021 | 1017 | 0.380 |
Why?
| | Male | 25 | 2024 | 63670 | 0.370 |
Why?
| | Gastroplasty | 1 | 2011 | 29 | 0.370 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 312 | 0.360 |
Why?
| | Gastric Bypass | 1 | 2011 | 108 | 0.330 |
Why?
| | Educational Status | 2 | 2022 | 471 | 0.330 |
Why?
| | Wisconsin | 5 | 2016 | 99 | 0.320 |
Why?
| | Neoadjuvant Therapy | 2 | 2023 | 379 | 0.320 |
Why?
| | Aged, 80 and over | 8 | 2024 | 7052 | 0.320 |
Why?
| | Databases, Factual | 5 | 2019 | 1269 | 0.320 |
Why?
| | Income | 2 | 2022 | 188 | 0.310 |
Why?
| | Reoperation | 3 | 2019 | 541 | 0.310 |
Why?
| | Pandemics | 3 | 2021 | 1491 | 0.300 |
Why?
| | Incidence | 5 | 2015 | 2641 | 0.300 |
Why?
| | Comorbidity | 3 | 2019 | 1547 | 0.290 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2023 | 377 | 0.290 |
Why?
| | Obesity, Morbid | 1 | 2011 | 241 | 0.280 |
Why?
| | Qualitative Research | 2 | 2024 | 1219 | 0.270 |
Why?
| | Preoperative Period | 2 | 2024 | 115 | 0.250 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 540 | 0.230 |
Why?
| | Lymphatic Metastasis | 3 | 2023 | 320 | 0.230 |
Why?
| | Inappropriate Prescribing | 1 | 2025 | 53 | 0.220 |
Why?
| | Patient Portals | 1 | 2024 | 42 | 0.220 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.220 |
Why?
| | Operating Rooms | 2 | 2023 | 115 | 0.210 |
Why?
| | Information Seeking Behavior | 1 | 2023 | 33 | 0.210 |
Why?
| | Hospital Mortality | 3 | 2016 | 848 | 0.210 |
Why?
| | Patient Navigation | 1 | 2024 | 78 | 0.210 |
Why?
| | Internet | 2 | 2024 | 618 | 0.210 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2046 | 0.200 |
Why?
| | Delivery of Health Care | 2 | 2022 | 898 | 0.190 |
Why?
| | Logistic Models | 3 | 2015 | 1986 | 0.190 |
Why?
| | Body Image | 1 | 2022 | 84 | 0.180 |
Why?
| | Electronics | 1 | 2021 | 74 | 0.180 |
Why?
| | Bone Marrow | 2 | 2020 | 273 | 0.180 |
Why?
| | Patient Discharge | 2 | 2020 | 836 | 0.180 |
Why?
| | Language | 1 | 2024 | 283 | 0.180 |
Why?
| | Receptor, ErbB-2 | 1 | 2023 | 326 | 0.180 |
Why?
| | Habits | 1 | 2020 | 44 | 0.180 |
Why?
| | Feasibility Studies | 1 | 2024 | 869 | 0.170 |
Why?
| | Patient Participation | 1 | 2024 | 414 | 0.170 |
Why?
| | Time Factors | 4 | 2022 | 6555 | 0.170 |
Why?
| | Checklist | 1 | 2021 | 93 | 0.170 |
Why?
| | Schools, Medical | 1 | 2021 | 136 | 0.170 |
Why?
| | Interdisciplinary Communication | 1 | 2021 | 184 | 0.170 |
Why?
| | Analgesia | 1 | 2021 | 100 | 0.170 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 70 | 0.170 |
Why?
| | Adaptation, Psychological | 2 | 2023 | 617 | 0.160 |
Why?
| | Nipples | 1 | 2019 | 8 | 0.160 |
Why?
| | Genotyping Techniques | 1 | 2019 | 72 | 0.160 |
Why?
| | Organ Sparing Treatments | 1 | 2019 | 32 | 0.160 |
Why?
| | Mentors | 1 | 2021 | 177 | 0.160 |
Why?
| | Health Education | 1 | 2022 | 335 | 0.160 |
Why?
| | Program Evaluation | 2 | 2021 | 875 | 0.160 |
Why?
| | Program Development | 1 | 2021 | 355 | 0.160 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 481 | 0.150 |
Why?
| | Hospitals, University | 2 | 2016 | 178 | 0.150 |
Why?
| | Breast Diseases | 1 | 2018 | 22 | 0.150 |
Why?
| | Career Choice | 1 | 2020 | 207 | 0.150 |
Why?
| | Patient Care Team | 2 | 2021 | 600 | 0.150 |
Why?
| | Pilot Projects | 1 | 2023 | 1592 | 0.150 |
Why?
| | Surface Properties | 1 | 2019 | 397 | 0.150 |
Why?
| | Guideline Adherence | 1 | 2022 | 527 | 0.150 |
Why?
| | Gene Frequency | 1 | 2019 | 502 | 0.150 |
Why?
| | Biopsy | 1 | 2022 | 1088 | 0.150 |
Why?
| | Postoperative Period | 2 | 2021 | 330 | 0.150 |
Why?
| | Salaries and Fringe Benefits | 1 | 2018 | 55 | 0.150 |
Why?
| | Sexual Behavior | 1 | 2022 | 481 | 0.140 |
Why?
| | Photography | 1 | 2018 | 93 | 0.140 |
Why?
| | Confidentiality | 1 | 2018 | 67 | 0.140 |
Why?
| | Risk Assessment | 2 | 2018 | 3262 | 0.140 |
Why?
| | Informed Consent | 1 | 2018 | 166 | 0.140 |
Why?
| | Anxiety | 1 | 2024 | 972 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1501 | 0.130 |
Why?
| | RNA, Viral | 1 | 2020 | 620 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 117 | 0.130 |
Why?
| | Alleles | 1 | 2019 | 847 | 0.130 |
Why?
| | Palliative Care | 1 | 2022 | 702 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1499 | 0.130 |
Why?
| | Proctocolectomy, Restorative | 1 | 2015 | 19 | 0.120 |
Why?
| | Medicare | 1 | 2020 | 708 | 0.120 |
Why?
| | Curriculum | 1 | 2021 | 920 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2014 | 10219 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1560 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2016 | 375 | 0.110 |
Why?
| | Rectum | 1 | 2015 | 170 | 0.110 |
Why?
| | Urinary Tract Infections | 1 | 2015 | 151 | 0.110 |
Why?
| | Colitis, Ulcerative | 1 | 2015 | 120 | 0.110 |
Why?
| | Emergencies | 1 | 2014 | 156 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 96 | 0.100 |
Why?
| | Age Factors | 1 | 2020 | 3152 | 0.100 |
Why?
| | Postoperative Care | 1 | 2014 | 241 | 0.100 |
Why?
| | Regression Analysis | 1 | 2015 | 997 | 0.100 |
Why?
| | Axilla | 2 | 2023 | 45 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2013 | 646 | 0.100 |
Why?
| | Global Health | 1 | 2015 | 328 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2019 | 3378 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1687 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 851 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2274 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1203 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1198 | 0.090 |
Why?
| | Treatment Failure | 1 | 2011 | 339 | 0.080 |
Why?
| | Adolescent | 4 | 2016 | 20412 | 0.080 |
Why?
| | Models, Biological | 1 | 2017 | 1724 | 0.080 |
Why?
| | Lymph Nodes | 2 | 2023 | 472 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3394 | 0.080 |
Why?
| | Disease Progression | 1 | 2017 | 2627 | 0.080 |
Why?
| | Cohort Studies | 1 | 2019 | 5426 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3717 | 0.070 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 749 | 0.070 |
Why?
| | Young Adult | 4 | 2019 | 12455 | 0.070 |
Why?
| | Laparoscopy | 1 | 2011 | 450 | 0.070 |
Why?
| | Weight Loss | 1 | 2011 | 738 | 0.060 |
Why?
| | Workflow | 1 | 2025 | 156 | 0.050 |
Why?
| | Mastectomy, Modified Radical | 1 | 2022 | 6 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 53 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2025 | 1282 | 0.040 |
Why?
| | Medical Oncology | 1 | 2022 | 269 | 0.040 |
Why?
| | Organizational Culture | 1 | 2021 | 138 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2019 | 54 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2019 | 66 | 0.040 |
Why?
| | Pain Measurement | 1 | 2021 | 508 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 170 | 0.040 |
Why?
| | ROC Curve | 1 | 2017 | 503 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 1970 | 0.030 |
Why?
| | Health Facility Size | 1 | 2014 | 11 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 39 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2014 | 317 | 0.030 |
Why?
| | Social Work | 1 | 2014 | 83 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 298 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 569 | 0.030 |
Why?
| | Health Care Costs | 1 | 2015 | 367 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5075 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 712 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 756 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 1019 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 439 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 505 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2564 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1720 | 0.020 |
Why?
| | Obesity | 1 | 2015 | 2882 | 0.010 |
Why?
|
|
Tevis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|